Biomedical Research Institute, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
School of Basic Medicine, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Infect Immun. 2021 Apr 16;89(5). doi: 10.1128/IAI.00016-21.
is an opportunistic pathogen that mostly affects patients with weakened immune systems, but a few serotypes (especially K1 and K2) are highly invasive and result in systemic infection in healthy persons. The ability to evade and survive the components of the innate immune system is critical in infection. To investigate the role and mechanism of transcription regulator KP1_RS12260 (KbvR) in virulence and defense against the innate immune response, deletion mutant and complement strains were constructed. The animal infection assay and antiphagocytosis assay demonstrate KbvR is an important regulator that contributes to virulence and the defense against phagocytosis of macrophages. The transcriptome analysis and phenotype experiments demonstrated that deletion of decreased production of capsular polysaccharide (CPS) and biosynthesis of partly outer membrane proteins (OMPs). The findings suggest that KbvR is a global regulator that confers pathoadaptive phenotypes, which provide several implications for improving our understanding of the pathogenesis of .
是一种机会性病原体,主要影响免疫系统较弱的患者,但少数血清型(尤其是 K1 和 K2)具有高度侵袭性,导致健康人群发生全身感染。逃避和存活于先天免疫系统成分的能力在感染中至关重要。为了研究转录调节因子 KP1_RS12260(KbvR)在毒力和防御先天免疫反应中的作用和机制,构建了缺失突变体和互补菌株。动物感染实验和抗吞噬实验表明,KbvR 是一个重要的调节因子,有助于毒力和防御巨噬细胞吞噬。转录组分析和表型实验表明,缺失会减少荚膜多糖(CPS)的产生和部分外膜蛋白(OMPs)的生物合成。这些发现表明,KbvR 是一个赋予病理适应表型的全局调节因子,这为我们理解 的发病机制提供了一些启示。